Mayo Clinic Study Links Distinct Gut Microbiome Signatures to Five Cancer Types and Early-Onset Disease
Mayo Clinic researchers published a study in Cell analyzing stool samples from 1,364 cancer patients, identifying 341 bacterial species linked to five specific cancer groups. The study found distinct microbiome patterns in adults under 50 with colorectal and breast cancer, including higher lactate levels and specific bacteria like Veillonella parvula. Additionally, pre-treatment gut bacteria levels predicted chemotherapy-induced diarrhea, specifically for 5-fluorouracil, offering a potential biomarker for treatment side effects.
